Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Consolidated Net Income (2023 - 2025)

Historic Consolidated Net Income for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to -$43.7 million.

  • CG Oncology's Consolidated Net Income fell 11422.34% to -$43.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$151.4 million, marking a year-over-year decrease of 10798.61%. This contributed to the annual value of -$88.0 million for FY2024, which is 8136.16% down from last year.
  • Latest data reveals that CG Oncology reported Consolidated Net Income of -$43.7 million as of Q3 2025, which was down 11422.34% from -$41.4 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Consolidated Net Income registered a high of -$8.7 million during Q1 2023, and its lowest value of -$43.7 million during Q3 2025.
  • Over the past 3 years, CG Oncology's median Consolidated Net Income value was -$18.9 million (recorded in 2024), while the average stood at -$23.3 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first tumbled by 6365.21% in 2024, then plummeted by 11904.81% in 2025.
  • CG Oncology's Consolidated Net Income (Quarter) stood at -$16.6 million in 2023, then tumbled by 92.16% to -$31.8 million in 2024, then tumbled by 37.43% to -$43.7 million in 2025.
  • Its last three reported values are -$43.7 million in Q3 2025, -$41.4 million for Q2 2025, and -$34.5 million during Q1 2025.